Html code here! Replace this with any non empty text and that's it.
Risk Factors for Progression of Immune Thrombocytopenia to Systemic Lupus Erythematosus
Researchers, led by Yuqing Song, sought to uncover potential risk factors driving progression of immune thrombocytopenia (ITP) to systemic lupus erythematosus (SLE) in pediatric...
The Great Debate: Belimumab or Voclosporin for Lupus Nephritis?
Editor's Note: This article was written by new DocWire News contributor Mithu Maheswaranathan, MD. Dr. Maheswaranathan is currently a practicing rheumatologist and Clinical Instructor...
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Receipt of an mRNA COVID-19 vaccine is not associated with severe disease flares in patients with rheumatic diseases, according to a study presented at...
Vaccination Rates Low Among Lupus Patients on Medicaid
Medicaid beneficiaries with systemic lupus erythematosus (SLE) who are not vaccinated are at risk for potentially avoidable acute care use for vaccine-preventable illnesses, according...
Patients with Rheumatic Disease Are Protecting Themselves from COVID-19—But At What Cost?
Patients with chronic rheumatic diseases (CRD) had much lower seroprevalence of SARS-CoV-2 antibodies compared to blood donors, but had higher rates of depression, increased...
Rheum Round-up: Tocilizumab and Diverticulitis Risk, Pulmonary Arterial Hypertension With Connective Tissue Disease, and...
Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to rituximab and abatacept in patients with rheumatoid arthritis (RA)...
Predicting Preterm Birth in Pregnancies of Women with Systemic Lupus Erythematosus
A study identified factors predictive of preterm birth in pregnant women with systemic lupus erythematosus (SLE), including a look at preconception care. Although developments in...
